Saturday, October 3, 2026

USD/CNH Is 1% Down In The Last 10 Sessions

ViaNews Editorial Team

January 22, 2024

USD/CNH Is 1% Down In The Last 10 Sessions

(VIANEWS) - USD/CNH (USDCNH) has been up by 1.85% for the last 10 sessions. At 16:06 EST on Monday, 22 January, USD/CNH (USDCNH) is $7.19.

USD/CNH's yearly highs and lows, it's 0.054% up from its 52-week low and 0.212% down from its 52-week high.

News about

  • Eur/usd forex signal - possible minor support $1.0900 - 22 January 2024. According to DailyForex on Monday, 22 January, "My previous EUR/USD signal on 15thJanuarywas not triggered as there was insufficiently bullish price action when the support level at $1.0936 was first reached that day.", "In my previous analysis ofthe EUR/USD currency pairone week ago, I wrote that the Consolidation between $1.0900 and $1.1000 was likely to continue, although I expected an eventual bullish breakout in the coming days or weeks beyond $1.1000. "
  • Eur/usd price analysis: hovers above 1.0900 followed by the 23.6% fibonacci level. According to FXStreet on Monday, 22 January, "The EUR/USD pair receives upward support on an improved risk appetite sentiment ahead of the European Central Bank's (ECB) January monetary policy meeting scheduled to be released on Thursday.", "Additionally, the trend-following momentum indicator suggests a confirmation of the bearish trend in the EUR/USD pair as the "Moving Average Convergence Divergence (MACD)" line lies below the centreline and shows a divergence below the signal line."
  • Eur/usd slightly dips below 1.0900 ahead of ecb’s decision. According to FXStreet on Monday, 22 January, "Although the EUR/USD headed south, it found support at the 200-day moving average (DMA) for two consecutive days in January 17 and 18, forming a 'tweezers bottom' chart pattern, that could open the door for further upside. "
  • Eur/usd: further downside potential based on the poor economic performance of the eurozone – rabobank. According to FXStreet on Monday, 22 January, "We continue to see risk of EUR/USD pushing lower to 1.0500 on a three-month view."
  • Eur/usd posts modest gains under the 1.0900 barrier on the softer US dollar. According to FXStreet on Monday, 22 January, "The EUR/USD pair posts modest gains under the 1.0900 barrier during the early Asian trading hours on Monday. "

More news about USD/CNH (USDCNH).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com